Renalytix Plc Share Price OTC Markets
Stocks
RNLXY
US75973T2006
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
OTC Markets
14:39:49 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3.590 USD | -1.91% |
|
-2.97% | -0.83% |
| 10-28 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-28 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 13.34M 11.95M 11.02M 9.97M 18.65M 1.27B 18.95M 131M 52.45M 665M 50.05M 48.98M 2.11B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 16.07M 14.82M 13.41M 25.08M 1.71B 25.49M 177M 70.54M 894M 67.31M 65.88M 2.83B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
81.69% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Renalytix Plc
| 1 day | -1.91% | ||
| 1 week | -2.97% | ||
| Current month | -5.28% | ||
| 1 month | -7.35% | ||
| 3 months | +87.51% | ||
| 6 months | +180.47% | ||
| Current year | -0.83% |
| 1 week | 3.59 |  | 3.92 |
| 1 month | 3.25 | | 4 |
| Current year | 1 | | 4.64 |
| 1 year | 1 | | 5.75 |
| 3 years | 1 | | 60 |
| 5 years | 1 | | 637.5 |
| 10 years | 1 | | 892.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 14/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 27/05/2024 |
Howard Doran
PSD | President | 65 | 29/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 14/03/2018 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 14/03/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -2.97% | - | - | 45.01M | |
| +0.06% | +4.28% | +26.36% | +62.51% | 260B | |
| +0.28% | +2.31% | +9.84% | +26.99% | 165B | |
| +0.88% | +1.01% | -16.60% | +73.44% | 154B | |
| -0.98% | -8.75% | -58.14% | -16.11% | 61.49B | |
| +2.95% | +4.80% | +14.18% | +51.40% | 52.9B | |
| +0.70% | +2.71% | -13.09% | -6.29% | 52.84B | |
| -1.87% | -3.38% | +8.71% | +63.78% | 51.46B | |
| -0.76% | +3.81% | +26.06% | +78.43% | 51.16B | |
| -0.07% | +4.85% | +39.08% | +101.82% | 46.85B | |
| Average | -0.08% | +1.34% | +4.04% | +48.44% | 99.52B | |
| Weighted average by Cap. | +0.21% | +1.41% | +6.72% | +50.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.05 1.89 1.71 3.2 217.98 3.25 22.57 9 114.08 8.59 8.41 361.31 | 3 2.69 2.48 2.24 4.19 285.68 4.26 29.58 11.8 149.51 11.26 11.02 473.54 |
| Net income | -33.46M -29.97M -27.65M -25.02M -46.78M -3.19B -47.54M -330M -132M -1.67B -126M -123M -5.28B | -20.4M -18.27M -16.86M -15.25M -28.53M -1.94B -28.99M -201M -80.23M -1.02B -76.56M -74.93M -3.22B |
| Net Debt | 3.86M 3.45M 3.19M 2.88M 5.39M 367M 5.48M 38M 15.16M 192M 14.47M 14.16M 609M | 4.6M 4.12M 3.8M 3.44M 6.43M 438M 6.54M 45.35M 18.09M 229M 17.26M 16.9M 726M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$3.590 | -1.91% | 12,736 |
| 28/10/26 | US$3.660 | -4.94% | 683 |
| 27/10/26 | US$3.850 | 0.00% | 192 |
| 23/10/26 | US$3.850 | +4.05% | 4,459 |
| 22/10/26 | US$3.700 | +3.35% | 168 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
- RNLXY Stock
Select your edition
All financial news and data tailored to specific country editions
